Navigation Links
Cancer Patients Should Steer Clear of Antioxidants
Date:5/27/2008

Research review suggests they may help cancer cells resist chemo, radiation

TUESDAY, May 27 (HealthDay News) -- A new review of existing research suggests that cancer patients undergoing radiation or chemotherapy avoid supplements with high levels of antioxidants.

Although multivitamins may be all right in some cases, even green tea and vitamin A or E supplements can spell trouble, said review author Dr. Brian Lawenda, clinical director of radiation oncology at Naval Medical Center in San Diego.

The supplements "may decrease the effectiveness of radiation or chemotherapy or even make the toxicities of these treatments worse," Lawenda said. "I would recommend that you do not take these agents during chemo or radiation."

According to Lawenda, many cancer patients take supplements and green tea because they think antioxidants will help their treatment. Antioxidants are generally considered healthy because they help protect cells against threats in the body.

"Everybody wants to take them," said Dr. Alfred Neugut, the head of cancer prevention and control for the Herbert Irving Comprehensive Cancer Center at Columbia University in New York City. "It comes up almost every day in almost anyone's practice."

But researchers have questioned the conventional wisdom, wondering whether antioxidants might actually harm cancer patients during treatment.

In the new review, reported in the May 27 online edition of the Journal of the National Cancer Institute, Lawenda and colleagues examined studies into antioxidants and cancer therapy.

The researchers found that only three studies on radiation and antioxidants relied on randomized controlled trials, which are considered the best way to compare medical treatments.

One of the studies found that antioxidant treatment appeared to raise the likelihood of death.

The antioxidants may protect cancer cells from harm just like they protect normal cells, Lawenda said, and therefore prevent cancer treatments from killing tumors.

The researchers did find 16 randomized controlled trials that looked at antioxidants and chemotherapy, but they said the findings weren't conclusive.

"The quality of these studies, in terms of many of the details, is not sufficient enough for us to make strong recommendations to our patients on the safety of using these agents during radiation or chemotherapy," Lawenda said.

Overall, however, the effect on life spans of taking antioxidants appears to be small, he added.

Lawenda said he tells his patients they can take a daily multivitamin, but he recommends they avoid high-dose supplements.

Still, "we don't know whether even a multivitamin is OK to take," he added. "We don't know if even the USDA levels are acceptable. We just don't know the answers to so many questions, unfortunately."

Neugut said the findings would change what he tells patients about antioxidant supplements.

"Since there's been little evidence on the subject, I've tended to be laissez-faire about it, figuring it probably couldn't hurt," he said. "This article suggests that it seems a little bit more likely that it's more harmful than helpful."

More information

Learn more about vitamins from the National Institutes of Health.



SOURCES: Brian Lawenda, M.D., clinical director, radiation oncology, Naval Medical Center, San Diego, and assistant professor, radiology and radiological sciences, Uniform University of Health Sciences, Bethesda, Md., and assistant professor of radiation oncology, Indiana University School of Medicine, Indianapolis; Alfred I. Neugut, M.D., Ph.D., professor, medicine and epidemiology, Columbia University College of Physicians and Surgeons, and head of cancer prevention and control, Herbert Irving Comprehensive Cancer Center, Columbia University, and co-director, cancer prevention, New York Presbyterian Hospital, New York City; May 27, 2008, Journal of the National Cancer Institute, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Common Genetic Variant Tied to Lung Cancer Risk
2. Verity Radiation Therapy Becomes Second U.S. Medical Center to Treat Cancer Patients Using RapidArc(TM) Radiotherapy Technology
3. Brown chemists create cancer-detecting nanoparticles
4. Gum Disease Might Boost Cancer Risk
5. Mayo Clinic researchers find common gene disorder doubles risk of lung cancer, even among nonsmokers
6. Laser Therapy a New Option for Vocal-Cord Cancers
7. Researchers find roadmap to next-generation cancer therapies
8. New Supporters Join the Prevent Cancer Foundation Mission
9. Cancer Survivors Develop Healthy Food Gift Business
10. What identifies cancer cells causing relapse and metastasis? Not CD133
11. Experimental agent blocks prostate cancer in animal study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Patients Should Steer Clear of Antioxidants
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: